 |
Odyssey Therapeutics
Last updated: September 10, 2025
Gary Glick, CEO
USA | Funding: $700M (+)
Website: https://odysseytx.com/
Odyssey Therapeutics is a computational immunology company that develops novel therapeutics for patients with autoimmune diseases.
Website: https://odysseytx.com/
Odyssey Therapeutics is a computational immunology company that develops novel therapeutics for patients with autoimmune diseases.
